Vaccination Antibody Testing for Dogs / Parvo, Distemper, Adenovirus (Dogs)

Pathogens / Biology

: Monitoring antibody titers in dogs focuses on the three pathogens targeted by the core canine vaccine: canine parvovirus (CPV-2, a non-enveloped DNA virus), canine distemper virus (CDV, an enveloped RNA virus of the Paramyxoviridae family), and canine adenovirus (CAV). Vaccination against infectious hepatitis (caused by CAV-1) is provided by the related CAV-2, which confers cross-immunity. Effective vaccines are available against all three pathogens, which generally provide long-term immunity.

Transmission / Epidemiology

Parvovirus, distemper, and infectious hepatitis often take a severe course in unvaccinated dogs and can be fatal; therefore, the corresponding vaccinations are considered core components worldwide. Maternal antibodies protect puppies during the first weeks of life, but they can also block the immune response to vaccination, and their duration varies from animal to animal. This highlights the need to monitor the development and maintenance of robust vaccine protection at both the individual animal and population levels.

Course & Symptoms

Parvovirus infection leads to severe, often bloody diarrhea, vomiting, and leukopenia, particularly in puppies. Canine distemper is a multisystemic disease with respiratory, gastrointestinal, and neurological signs. Infectious hepatitis primarily affects the liver and vascular endothelium. Since effective vaccines are available against all three pathogens, ensuring adequate protection is the primary focus of preventive management.

Diagnostic Relevance

For canine parvovirus, distemper virus, and adenovirus, there is a strong correlation between a detectable antibody titer and protection against disease. A positive antibody test result indicates existing vaccine protection, so routine booster shots are generally not necessary. Antibody testing is therefore suitable for individually assessing the need for revaccination, verifying the success of the primary immunization following the puppy vaccination series, or determining the appropriate vaccination timing for young animals after maternal antibodies have waned. The antibody titer is a measure of vaccination or immune status and not evidence of an acute infection; its diagnostic value is limited in animals with acute or chronic disease, so laboratory-based reference methods should be used when in doubt.

Rapid Test Component

The Fassisi® CantiCheck MPX detects antibodies against parvovirus, distemper virus, and adenovirus in serum, plasma, or whole blood, thereby supporting the assessment of vaccine protection and the decision regarding a booster vaccination. For determining antibody or vaccination titers; not for the acute detection of pathogens.

Sources for the information provided.